Skip to content
CancerIndex

Loading the knowledge graph…

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). — knowledge graph · CancerIndex